Core Viewpoint - Zhendemedical (603301) is initiating hedging activities to mitigate the impact of raw material price fluctuations on its operations, with a focus on polyethylene, polypropylene, and rubber [1][2]. Group 1: Stock Performance - As of November 20, 2025, Zhendemedical's stock closed at 77.0 yuan, down 1.8% from the previous trading day, with a total market capitalization of 20.517 billion yuan [1]. - The stock opened at 78.8 yuan, reached a high of 79.94 yuan, and a low of 76.76 yuan, with a trading volume of 3.78 billion yuan and a turnover rate of 1.83% [1]. Group 2: Hedging Business Announcement - The company plans to engage in financial derivative hedging related to raw materials to reduce the impact of price volatility on its operations [1]. - The maximum trading margin is set at 30 million yuan, with a maximum contract value not exceeding 200 million yuan, funded by the company's own resources [1]. - The trading period will last for 12 months from the date of approval by the board of directors, and this initiative has been approved by the fourth meeting of the company's fourth board of directors without requiring shareholder meeting approval [1]. Group 3: Risk Management - The company acknowledges potential risks associated with market, policy, performance, technology, and operational aspects, and has established corresponding risk control measures [1].